MARKET COMPOSITE
Market TodayThemes and Stocks SummaryThematic Stock SearchFAQAbout
Home/
CVM - Cel-Sci Corp.8:00:00 PM 4/26/2024
Price
$1.44
-0.01 (-0.69%)
Cel-Sci Corporation , is a biotechnology company that is testing drugs for the treatment of cancer, autoimmune and infectious diseases through the research and development of immunotherapy products. Cel-Sci's main product is the drug Multikine, an immunotherapeutic agent designed to fight cancer by stimulating the body's immune system. Multikine is currently in Phase III of Clinical Trials with the Food and Drug Administration . The therapeutic has also been referred to as Leukocyte Interleukin Injection . Multikine was in Phase II testing of patients with head and neck cancer in the early 2000s, in which it demonstrated tumor-reducing ability. In January 2007, the US cleared the Phase 3 trial and Multikine was designated as an orphan drug by the FDA for neoadjuvant therapy of patients with squamous cell carcinoma of the head and neck. 928 patients were enrolled in the head and neck cancer drug trial at that time.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related
Topics
Biotechnology1.50%
Peers
AMGN0.20%
BCRX0.00%
CASI5.20%
CRIS-0.30%
EBS-1.50%
JNJ-0.50%
TEVA4.20%
XNCR3.90%
leak data
Stock news

Load more